Aravind R. Sanjeevaiah, MD, discusses the benefit of immunotherapy agents in the treatment of patients with gastric cancers.
Aravind R. Sanjeevaiah, MD
Advertisement
Articles by Aravind R. Sanjeevaiah, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
2
CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma
3
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
4
FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma
5